drugset / Trial / NCT02212756
Pharmacokinetic Profiles of Metformin With DW1029M
RandomizedCrossoverOpen-labelHealth-services research
Summary
Phase I clinical study to evaluate DW1029M influence the pharmacokinetic profiles of Metformin after oral administration in healthy male volunteer
Timeline
- Start
- 2014-08
- Primary completion
- 2015-01
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DW1029M | Unknown | 1200 mg | Oral |
| Subject | Metformin | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.